n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide has been researched along with n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride in 1 studies
Studies (n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide) | Trials (n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide) | Recent Studies (post-2010) (n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide) | Studies (n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride) | Trials (n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride) | Recent Studies (post-2010) (n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride) |
---|---|---|---|---|---|
11 | 0 | 0 | 6 | 0 | 3 |
Protein | Taxonomy | n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide (IC50) | n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride (IC50) |
---|---|---|---|
Urokinase-type plasminogen activator | Homo sapiens (human) | 0.41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bode, W; Dönnecke, D; Friedrich, R; Müller, F; Schuster, O; Schweinitz, A; Steinmetzer, P; Steinmetzer, T; Stürzebecher, A; Stürzebecher, J; Than, ME; Uhland, K | 1 |
1 other study(ies) available for n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide and n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride
Article | Year |
---|---|
Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.
Topics: Amides; Amidines; Animals; Catalytic Domain; Crystallography, X-Ray; Humans; Kinetics; Male; Mice; Mice, Nude; Models, Molecular; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship; Sulfones; Xenograft Model Antitumor Assays | 2006 |